Dr. Reddy’s Laboratories was responsible for conducting Phase III clinical trials of the Sputnik V vaccine in India.
Sputnik V is a viral vector-based COVID-19 vaccine developed by the Gamaleya Research Institute.
Its two-dose regimen aims to provide robust immunity against SARS-CoV-2.